The impact of insurance status on psoriasis patients’ healthcare-seeking behavior: a population-based study in the United States
This study found that psoriasis patients with public-only insurance were significantly more likely to delay seeking or receiving care compared to those with private insurance. This study also found that uninsured psoriasis patients were significantly more likely to be unable to obtain care than psoriasis patients with private insurance and those with public-only insurance. Developing strategies to increase healthcare access is necessary to ensure equitable, timely, and appropriate care for all psoriasis patients, regardless of their insurance status.
Authors
- Robin Kikuchi
- Sara Bilimoria (ORCID: https://orcid.org/0000-0003-3044-1571)
- April Wang Armstrong (ORCID: https://orcid.org/0000-0003-0064-8707)
- Kaviyon Sadrolashrafi (ORCID: https://orcid.org/0000-0003-1964-4052)
- Danielle Yee (ORCID: https://orcid.org/0000-0002-0486-2033)
- Hannah C. Tolson (ORCID: https://orcid.org/0009-0000-1564-6056)
- Rebecca K. Yamamoto (ORCID: https://orcid.org/0009-0005-4854-9128)
- Lily Guo (ORCID: https://orcid.org/0000-0002-3777-0039)
- Audrey Hao (ORCID: https://orcid.org/0009-0003-3327-1261)
Institutions
- University of Southern California (US)
- University of Nevada, Las Vegas (US)
- University of Arizona (US)
- University of California, Los Angeles (US)
- Duke University (US)
- University of Phoenix (US)
- Georgetown University (US)
- UCLA Medical Center (US)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1186/s12913-024-11992-z
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- Sanofi
- Regeneron Pharmaceuticals
- Dermira
- Incyte